Greenwich LifeSciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q2 2024 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q3 2024 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q1 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q2 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q3 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
| Q4 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
Greenwich LifeSciences, Inc. Earnings Date And Information
Greenwich LifeSciences, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.2 earnings per share for the quarter, missing analysts' consensus estimates of $-0.2 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Greenwich LifeSciences, Inc. has generated $-1 earnings per share over the last year ($-0.69 diluted earnings per share) and currently has a price-to-earnings ratio of -15.49. Greenwich LifeSciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
Greenwich LifeSciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.20 | $0 | $0 | ||
| 08/14/2024 | Q2 2024 | -$0.20 | -$0.20 | 0 | $0 | $0 |
| 05/20/2024 | Q1 2024 | -$0.20 | -$0.19 | 0.01 | $0 | |
| 04/15/2024 | Q4 2023 | -$0.21 | $5,418 | |||
| 10/19/2023 | Q3 2023 | -$0.22 | -$0.19 | 0.03 | $0 | |
| 08/21/2023 | Q2 2023 | -$0.23 | -$0.13 | 0.1 | $0 | |
| 05/22/2023 | Q1 2023 | -$0.23 | -$0.16 | 0.07 | $0 | |
| 03/31/2023 | Q4 2022 | $0.18 | -$0.21 | -0.39 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.19 | -$0.18 | 0.01 | $0 | |
| 08/15/2022 | Q2 2022 | -$0.19 | -$0.06 | 0.13 | $0 | |
| 05/20/2022 | Q1 2022 | -$0.19 | -$0.15 | 0.04 | $0 | |
| 03/21/2022 | Q4 2021 | -$0.07 | -$0.18 | -0.11 | $0 | |
| 11/15/2021 | Q3 2021 | -$0.06 | -$0.07 | -0.01 | $0 | |
| 08/13/2021 | Q2 2021 | -$0.06 | $0 | |||
| 05/20/2021 | Q1 2021 | -$0.26 | -$0.05 | 0.21 | $0 | |
| 03/31/2021 | Q4 2020 | -$0.93 | -$0.13 | 0.8 | $0 | |
| 11/16/2020 | Q3 2020 | -$0.02 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.02 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.02 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.03 | $0 |
Greenwich LifeSciences, Inc. Earnings: Frequently Asked Questions
-
When is Greenwich LifeSciences, Inc.'s earnings date?
Greenwich LifeSciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
How can I listen to Greenwich LifeSciences, Inc.'s earnings conference call?
The conference call for Greenwich LifeSciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Greenwich LifeSciences, Inc.'s conference call transcript?
The conference call transcript for Greenwich LifeSciences, Inc.'s latest earnings report can be read online.
-
How much profit does Greenwich LifeSciences, Inc. generate each year?
Greenwich LifeSciences, Inc. (:GLSI) has a recorded net income of $0. Greenwich LifeSciences, Inc. has generated $-0.69 earnings per share over the last four quarters.
-
What is Greenwich LifeSciences, Inc.'s price-to-earnings ratio?
Greenwich LifeSciences, Inc. (:GLSI) has a price-to-earnings ratio of -15.49 and price/earnings-to-growth ratio is 12.24.
